HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meningococcal purpura fulminans treated with antithrombin III concentrate: what is the optimal replacement therapy?

AuthorsR Cobcroft, A Henderson, C Solano, D Scott
JournalAustralian and New Zealand journal of medicine (Aust N Z J Med) Vol. 24 Issue 5 Pg. 575-6 (Oct 1994) ISSN: 0004-8291 [Print] Australia
PMID7848164 (Publication Type: Case Reports, Letter)
Chemical References
  • Antithrombin III
Topics
  • Adolescent
  • Antithrombin III (administration & dosage)
  • Humans
  • Infusions, Intravenous
  • Male
  • Meningococcal Infections (complications)
  • Neisseria meningitidis
  • Purpura (complications, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: